Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory Malignancies

NCT00050687 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

INDUSTRY

Sponsor class

Conditions

Prostatic Neoplasms
Multiple Myeloma
Bladder Neoplasms
Lymphoma

Interventions

DRUG: Gallium maltolate

Sponsor

Titan Pharmaceuticals